Summary of work
For any patient with end-stage kidney disease (ESKD), waiting for a donor kidney is a lengthy, draining and stressful process, adding to the mental and physical burden of the disease and dependency upon dialysis. For those patients who are ’highly sensitised’, and immunologically incompatible with most potential donors, ensuring a state of ‘transplant-readiness’ is even more challenging.
Hansa Biopharma is in the pre-commercialisation phase of a therapy that it is hoped will increase transplant eligibility among this highly sensitised population. Recognising an unmet need for comprehensive support for all ESKD patients through the renal transplantation journey, Hansa commissioned the trans*PLAN programme. This global, multilingual initiative provides a virtual Transplant Community Centre supported by a behavioural change programme, designed to enable patients to access a range of instructive, life-enhancing resources and take control of their own transplant journey.
We describe the developmental stage of trans*PLAN, representing a collaborative effort between Bedrock Healthcare Communications, Sprout Behaviour Change, Syneos Health and Backpack Health. A combination of international market research, analysis of published literature, beta testing of hosting technology and engagement of patient associations has supported the design of the trans*PLAN programme and laid the foundations for its implementation.
Bedrock Healthcare Communications really made an effort to develop a thorough understanding of what they wanted to achieve. They showed a thorough identification of the clinical community and will clearly enhance HCP and patient experience of transplant over time. The judges look forward to seeing this project develop.